Notícias e Atividades da Amicus Therapeutics
Presença
Amicus Therapeutics é uma das ...
Amicus Therapeutics é uma empresa listada sob o símbolo FOLD (US).
Amicus Therapeutics tem presença direta em 5 países.Amicus Therapeutics possui 4 subsidiárias incluindo Amicus Therapeutics France, Amicus Therapeutics Germany e Amicus Therapeutics Spain.
Executivos
Veja o organograma con seus 36 executivos principais
Biografias mais buscadas da Amicus Therapeutics
- Bradley Campbell, President and Chief Executive Officer
- Craig Wheeler, Director
- Margaret McGlynn, Director
Criar um alerta
para seguir os movimentos de executivos da Amicus Therapeutics.
Biotecnologia
Amicus Therapeutics possui 2.349 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Genus (Reino Unido).
Popular M&A news in Biotecnologia
- Taiho Pharmaceutical has announced the acquisition of Araris Biotech (publicado em 3 de abril de 2025).
- Maxion Therapeutics acaba de anunciar uma arrecadação de fundos de 72 milhões de dólares. (publicado em 3 de abril de 2025).
- Lantheus Holdings adquiriu Evergreen Theragnostics (publicado em 2 de abril de 2025).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Amicus Therapeutics
- Amicus Therapeutics to Announce Third Quarter 2020 Financial Results on November 5, 2020 | Amicus Therapeutics
- Amicus Therapeutics Announces Additional Positive Interim Clinical Data for CLN6 Batten Disease Gene Therapy at 49th Annual Meeting of the Child Neurology Society | Amicus Therapeutics
- Amicus Therapeutics Announces Additional Positive Interim Clinical Data for CLN6 Batten Disease Gene Therapy at 49th Annual Meeting of the Child Neurology Society | Amicus Therapeutics
- Amicus Therapeutics Receives European Medicines Agency PRIME Designation for CLN6 Batten Disease Gene Therapy | Amicus Therapeutics
- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2020 | Amicus Therapeutics
- Amicus Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates | Amicus Therapeutics
- Amicus Therapeutics to Present at the BTIG Virtual Biotechnology Conference | Amicus Therapeutics
- Amicus Therapeutics to Announce Second Quarter 2020 Financial Results on August 10, 2020 | Amicus Therapeutics
- Amicus Therapeutics Secures $400 Million Non-Dilutive Debt Financing | Amicus Therapeutics
- Amicus Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference | Amicus Therapeutics
- View more press releases Close
Redes sociais sobre Amicus Therapeutics
- Amicus Therapeutics na Wikipedia, Google News e Yahoo Finance
- Amicus Therapeutics na LinkedIn, Twitter e YouTube
